PYPD
Polypid Ltd

929
Mkt Cap
$73.45M
Volume
23,199.00
52W High
$5.12
52W Low
$2.30
PE Ratio
-1.55
PYPD Fundamentals
Price
$4.59
Prev Close
$4.62
Open
$4.60
50D MA
$4.33
Beta
0.35
Avg. Volume
81,236.05
EPS (Annual)
-$2.09
P/B
3.06
Rev/Employee
$0.00
$67.17
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of -$0.41 up 63.72% YoY • PolyPid anticipates beginning its rolling NDA submission for D-PLEX100 by the end of the first quarter of 2026. The company believes its cash balance will fund operations into the second half of 2026 through significant milestones.

Bullish

PolyPid achieved positive FDA pre-NDA feedback and plans D-PLEX100 submission by Q1 2026. The company also unveiled Kynatrix Technology and improved net loss per share.

Bearish

PolyPid experienced increased operating expenses and a decline in cash to $12.9M. The company's reliance on external partnerships for D-PLEX100 commercialization presents a structural market risk.

Latest PYPD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.